Grace R. Macklin

Avenue Appia 20
Appia, GE 1211, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020-2021): a cross-sectional study.

Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020-2021): a cross-sectional study.

Journal: The Lancet regional health. Southeast Asia

Published: June 20, 2024

Three-dose immunogenicity of the type 2 novel oral poliovirus vaccine in a campaign setting in Tajikistan: a follow-up study.

Three-dose immunogenicity of the type 2 novel oral poliovirus vaccine in a campaign setting in Tajikistan: a follow-up study.

Journal: The Lancet. Global health

Published: December 22, 2023

Mucosal Immunity to Poliovirus in Children 0-15 Years of Age: A Community-Based Study in Karachi, Pakistan in 2019.

Mucosal Immunity to Poliovirus in Children 0-15 Years of Age: A Community-Based Study in Karachi, Pakistan in 2019.

Journal: The Journal of infectious diseases

Published: July 13, 2023

Use of inactivated poliovirus vaccine for poliovirus outbreak response.

Use of inactivated poliovirus vaccine for poliovirus outbreak response.

Journal: The Lancet. Infectious diseases

Published: June 30, 2023

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses.

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses.

Journal: Gates open research

Published: April 03, 2023

Two-Year Duration of Immunity of Inactivated Poliovirus Vaccine: A Follow-up Study in Pakistan in 2020.

Two-Year Duration of Immunity of Inactivated Poliovirus Vaccine: A Follow-up Study in Pakistan in 2020.

Journal: The Journal of infectious diseases

Published: January 13, 2023

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey.

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey.

Journal: The Lancet. Global health

Published: August 02, 2022

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.

Journal: MMWR. Morbidity and mortality weekly report

Published: June 16, 2022

Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021.

Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021.

Journal: The Lancet. Global health

Published: April 21, 2022

Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020.

Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020.

Journal: Vaccine

Published: September 06, 2021

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.

Journal: Vaccine

Published: August 24, 2021

Fractional-dose IPV in polio eradication.

Fractional-dose IPV in polio eradication.

Journal: The Lancet. Infectious diseases

Published: September 10, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026